Remove 2021 Remove Communication Remove Immunity
article thumbnail

As the Prospect of a Vaccine Approaches, Business and Communications Challenges Are Just Around the Corner

Eye on FDA

Vaccination may start next month, but the effects will not occur until after a period following the second dose which would occur in 2021. Vaccination for COVID-19 not only requires business planning, but communications planning in support of the decisions. But first there will be regulatory rites of passage.

article thumbnail

High levels of exposure to COVID virus may reduce protection from vaccination, prior infection: Study

Express Pharma

The study was performed to understand whether the immunity gained after vaccination or a prior infection was less effective or “leaky” in situations where people are exposed to high levels of the virus.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Pharmaceutical Technology

The technology utilises outer membrane vesicles (OMVs) to deliver antigens, often eliminating the need for adjuvants while triggering the immune response. The partnership strengthens GSK’s current relationship with the Indian company, which began with a product transfer and licence agreement in 2021 for the malaria vaccine, RTS,S.

article thumbnail

COVID-19: Helping to support momentum on antimicrobial innovation

pharmaphorum

To mark World Antimicrobial Awareness Week NovaBiotics’s Deborah O’Neil tells us why 2021 might be the year anti-infective drugs finally demonstrate their economic value. . 2021 could be the year that they demonstrate their economic case. Let’s use Antimicrobial Awareness Week to get that message out. About the author.

article thumbnail

Digital innovation drives vaccine development

pharmaphorum

Pfizer’s Digital Innovation Lab recently sponsored a Vaccines Global Innovation Challenge and provided four finalists with a worldwide audience to pitch to at the Frontiers Health conference on November 11-12, 2021. In the end, the winners of the Challenge were Medorion and Telesofia Medical. Innovation at Pfizer.

article thumbnail

NICE recommends Kite’s CAR-T therapy to treat lymphoma

Pharmaceutical Technology

It takes own immune cells of a patient and modifies them to attach and destroy cancer cells. Between December 2018 and October 2021 in England, 318 people received axicabtagene ciloleucel through the CDF. The new CAR-T therapy will be given as a one-off intravenous infusion. months and 45% of them were alive after three years.

article thumbnail

argenx enrols new cohort in Phase II multifocal motor neuropathy study

Pharmaceutical Technology

The only MMN therapies currently available are immune globulin, with many pipeline therapies being the same. But argenx claims that this leaves a gap in the market since patients receiving immune globulin often still experience disease progression. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.